Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

MGF Peptide and Research in Muscle Cells - Core Peptides

MGF Peptide and Research in Muscle Cells Dec 9, 2021 What is MGF Peptide? Mechano Growth Factor (MGF) is a derivative of Insulin-Like Growth Factor-1 (IGF-1), a hormone with a molecular structure similar to insulin. MGF is a peptide product of peptide splicing

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

MGF Peptide and Research in Muscle Cells

Dec 9, 2021

What is MGF Peptide?

Mechano Growth Factor (MGF) is a derivative of Insulin-Like Growth Factor-1 (IGF-1), a hormone with a molecular structure similar to insulin. MGF is a peptide product of peptide splicing and is closely correlated with IGF-1. The hormone IGF-1, also known as Somatomedin C, is an insulin-like hormone. It has 70 amino acids in a single chain with three intramolecular disulfide bridges. IGF-1 is mainly produced in the liver, though researchers have observed its generation in target tissues elsewhere in the paracrine. The main stimulus for its production is Growth Hormone (GH). IGF-1 circulates and is bound to one of the six binding proteins, considered primarily to bind to IGFBP-3.

Research

Naturally occurring IGF-1 has been widely researched, and scientists have isolated MGF in the hopes of enhancing on specific proposed characteristics of IGF-1. Researchers have suggested MGF may hold potentially analogous action due to its apparent specific action on muscle satellite cells.

Muscle satellite cells are multi-potent stem cells, classified as ‘undifferentiated cells.’ In other words, they are considered to divide, re-divide, and mature into various types of cells. Their proliferation appears to play a role in tissue regeneration and muscle mass build-up through the increase in the number of muscle fibers. Researchers have reported MGF may introduce them back into the cell cycle, which may help them to perform these functions.

Additionally, MGF may exhibit neuroprotective potential in ischaemic brain tissue. This is attributed to its possible capacity to reduce neuronal loss and infarct area.

BPC-157 and TB-500 have been heavily researched for their potential in tissue repair and cell function maintenance. Recent studies suggest that MGF may exert similar impact, expressed as pulses following muscle damage, which has been linked to the activation of muscle satellite (stem) cells. Once activated, these stem cells appear to divide and differentiate to form muscle fibers, possibly resulting in hastened tissue repair.

MGF Peptide and Muscle Cells

Researchers have posited through cell research that certain MGF characteristics may mirror similar action on muscle cell development as anabolic-androgenic steroids. Further research in this field within laboratory settings have supported the hypothesis that MGF may potentially produce similar action as steroids on muscle cell proliferation and development, and that it may exhibit focused the action of muscle satellite cells. Unlike steroids, MGF was not observed in the course of the research studies to have exhibited systemic impacts or to have targeted other organs.

NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering.

Dr. Marinov

Dr. Marinov (MD, Ph.D.) is a researcher and chief assistant professor in Preventative Medicine & Public Health. Prior to his professorship, Dr. Marinov practiced preventative, evidence-based medicine with an emphasis on Nutrition and Dietetics. He is widely published in international peer-reviewed scientific journals and specializes in peptide therapy research.

Latest Blog Articles

Thymogen Potential in Immune Cell Regulation

CJC-1295 & Hexarelin Blend Potential for Growth Hormone Signaling Stimulation

Oxytocin Actions On Neuronal Circuits in Different Mammalian Research Models

Kisspeptin 45-54 Peptide Interactions with Hypothalamic and Neuronal Cells

T-31 Peptide Interactions with Cellular Aging, Renewal, and Stress Pathways

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

PSPeptides vs Core Peptides: A Direct Comparison

The most useful way to evaluate core peptides alternatives is a direct, factor-by-factor comparison. The table below shows how PSPeptides stacks up against Core Peptides across the criteria…

Source: pspeptides.com
Research context

Read sources and limitations before applying a claim.

Research

Researchers generally cease Hexarelin exposure within 2 weeks of initial introduction, as seen on average within the body of research on animal models. Doing otherwise was reported in some studies to potentially lead to an insignificant rise in growth hormone production due to, potentially, an increase in desensitization. A study opposing this practice was conducted. The experiment was performed on animal research subjects to examine Hexarelin’s desensitization rate in daily exposure. The subjects’ blood was drawn four times over 16 weeks and analyzed. Upon evaluation, the researchers concluded that Hexarelin appeared to have presented an insignificant difference in desensitization after the first and fourth week of exposure. Animal subjects exposed to Hexarelin reportedly presented muscle size increases, likely resulting from new myocytogenesis. Hexarelin also displayed accelerated injury recovery and, in some cases, was observed to have benefited cardiac functioning. Animal subjects without the ability to generate their own hGH naturally, were observed over the course of the study. The peptide has also been researched for its potential to increase epidermal elasticity, and has been suggested by researchers to exhibit properties that encompass possible injury prevention through increased epidermal structure and strength, and hastened recovery in damaged tissue. Hexarelin has been suggested to provide a variety of properties, with its most prominent potential actions speculated within the realm of fat regulation, cardiac protection, and muscle mass preservation. Initial research supports Hexarelin’s potential as a CD36 agonist, a protein involved in lipolysis control, and management of fatty acid breakdown. Exposure of cultured murine adipose to Hexarelin reportedly resulted in CD36 activation, which scientists reported drew out the reduced expression of PEPCK.(2) Since PEPCK is linked to the breakdown of fatty acids, this implies that this process may be regulated by CD36, and may potentially be thus activated by this peptide. Abnormal amounts of fat in the blood are referred to as dyslipidemia. Rodent research suggests that growth hormone-releasing peptide 6 (GHRP-6) may potentially inhibit dyslipidemia in an insulin resistance setting while lowering blood sugar and insulin resistance. Hexarelin may potentially provide an alternative to the lipid compounds currently widespread in research studies within the context of severe dyslipidemia.

Source: corepeptides.com ↗

Oxytocin Actions On Neuronal Circuits in Different Mammalian Research Models

Jun 30, 2026 Oxytocin is posited to be a cyclic nonapeptide composed of nine amino acids in the sequence Cys–Tyr–Ile–Gln–Asn–Cys–Pro–Leu–Gly-NH2 (CYIQNCPLG-NH2), with a molecular weight of approximately 1007 Da....

Source: corepeptides.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →